Drug intelligence / Profile preview

rClone30-IL-12

Development stage
Preclinical
Lead developer
Northeast Agricultural University
Modality
Oncolytic Viruses → Oncolytic Therapeutics, Cytokines & Interferons → Recombinant Proteins and Enzymes
Administration
Intratumoral
01

Overview

rClone30-IL-12 is a genetically engineered oncolytic Newcastle disease virus (NDV) based on the Clone 30 strain, designed to express the cytokine interleukin-12 (IL-12). As an oncolytic virus, it selectively infects and lyses tumor cells while simultaneously delivering IL-12 to the tumor microenvironment. IL-12 is a potent immunomodulator that stimulates T-cell and natural killer (NK) cell activity and promotes the secretion of interferon-gamma (IFN-γ), thereby enhancing the host's anti-tumor immune response. Preclinical studies have demonstrated its efficacy in inhibiting tumor growth and improving survival in various cancer models, including hepatoma and glioma.

Other names
recombinant Newcastle disease virus expressing interleukin-12
02

Targets

IL-12R (Interleukin-12 receptor)

Beyond the preview

Go deeper on rClone30-IL-12.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rClone30-IL-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call